Prognosis of Perihilar Cholangiocarcinoma: Hilar Bile Duct Cancer versus Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus (original) (raw)

Abstract

Background

Clinically hepatobiliary resection is indicated for both hilar bile duct cancer (BDC) and intrahepatic cholangiocarcinoma involving the hepatic hilus (CCC). The aim of this study was to compare the long-term outcome of BDC and CCC.

Methods

Between 1990 and 2004, we surgically treated 158 consecutive patients with perihilar cholangiocarcinoma. The clinicopathological data on all of the patients were analyzed retrospectively.

Results

The overall 3-year survival rate, 5-year survival rate, and median survival time for BDC patients were 48.4%, 38.4 %, and 33.7 months, respectively, and 35.8%, 24.5 %, and 22.7 months, respectively, in CCC patients (P = .033).

On multivariate analysis, three independent factors were related to longer survival in BDC patients: achieved in curative resection with cancer free margin (R0) (P = .024, odds ratio 1.862), well differentiated or papillary adenocarcinoma (P = .011, odds ratio 2.135), and absence of lymph node metastasis (P < .001, odds ratio 3.314). Five factors were related to longer survival in CCC patients: absence of intrahepatic daughter nodules (P < .001, odds ratio 2.318), CEA level ≤2.9 ng/mL (P = .005, odds ratio 2.606), no red blood cell transfusion requirement (P = .016, odds ratio 2.614), absence or slight degree of lymphatic system invasion (P < .001, odds ratio 4.577), and negative margin of the proximal bile duct (P = .003, odds ratio 7.398).

Conclusions

BDC and CCC appear to have different prognoses after hepatobiliary resection. Therefore, differentiating between these two categories must impact the prediction of postoperative survival in patients with perihilar cholangiocarcinoma.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14:535–43
    Article PubMed CAS Google Scholar
  2. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130:270–6
    PubMed CAS Google Scholar
  3. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weiman A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15:947–54
    PubMed CAS Google Scholar
  4. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808–18
    Article PubMed CAS Google Scholar
  5. Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575–83
    Article PubMed CAS Google Scholar
  6. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663–71
    Article PubMed CAS Google Scholar
  7. Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7:155–62
    Article PubMed CAS Google Scholar
  8. Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma: a single center experience. Surgery 2000; 127:395–404
    Article PubMed CAS Google Scholar
  9. Lee SG, Lee YJ, Park KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 2000; 7:135–41
    Article PubMed CAS Google Scholar
  10. Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73–83
    Article PubMed Google Scholar
  11. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84–92
    Article PubMed Google Scholar
  12. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg 2005; 241:693–702
    Article PubMed Google Scholar
  13. Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241:703–14
    Article PubMed Google Scholar
  14. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resection for perihilar cholangiocarcinoma with zero mortality. Ann Surg 2006; 244:240–7
    Article PubMed Google Scholar
  15. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521–7
    PubMed CAS Google Scholar
  16. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006; 243:364–72
    Article PubMed Google Scholar
  17. Sano T, Kamiya J, Nagino M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6:101–7
    Article PubMed CAS Google Scholar
  18. Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss; 2002
    Google Scholar
  19. Cox D, Oakes D. Analysis of Survival Date. London: Chapman and Hall; 1983
    Google Scholar
  20. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterolog 1991; 38:170–5
    CAS Google Scholar
  21. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463–73
    Article PubMed CAS Google Scholar
  22. Jarnagin WR, Klimstra DS, Hezel M, et al. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 2006; 24:1152–60
    Article PubMed CAS Google Scholar
  23. Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004; 240:95–101
    Article PubMed Google Scholar
  24. Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 1998; 227:405–11
    Article PubMed CAS Google Scholar
  25. Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 2002; 89:1260–7
    Article PubMed CAS Google Scholar
  26. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2004; 103:1210–6
    Article Google Scholar
  27. Sakamoto Y, Kosuge T, Shimada K, et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and excisional margins. Surgery 2005; 137:396–402
    Article PubMed Google Scholar
  28. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994; 115:303–9
    PubMed CAS Google Scholar

Download references

Acknowledgment

This research was supported in part by a Grant-in-Aid for scientific research from the Ministry of Health and Welfare of Japan.

Author information

Authors and Affiliations

  1. Hepato-Biliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
    Tsuyoshi Sano MD, Kazuaki Shimada MD, Yoshihiro Sakamoto MD, Minoru Esaki MD & Tomoo Kosuge MD
  2. Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
    Hidenori Ojima MD

Authors

  1. Tsuyoshi Sano MD
  2. Kazuaki Shimada MD
  3. Yoshihiro Sakamoto MD
  4. Hidenori Ojima MD
  5. Minoru Esaki MD
  6. Tomoo Kosuge MD

Corresponding author

Correspondence toTsuyoshi Sano MD.

Additional information

T. Sano is currently with: Hepato-Biliary and Pancreatic Surgery Division, Aichi Cancer Center Hospital, Nagoya, Japan.

Rights and permissions

About this article

Cite this article

Sano, T., Shimada, K., Sakamoto, Y. et al. Prognosis of Perihilar Cholangiocarcinoma: Hilar Bile Duct Cancer versus Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus.Ann Surg Oncol 15, 590–599 (2008). https://doi.org/10.1245/s10434-007-9687-y

Download citation

Keywords